Medications 7 min read

Wellbutrin (Bupropion)

Wellbutrin is the weird cousin in the antidepressant family. Most of what people think of as antidepressants are SSRIs, which work on serotonin and have a pretty consistent personality: they take the edge off, they flatten emotional range a bit, they often kill your libido, and a fair number of people gain weight on them. Wellbutrin doesn’t do any of that. It doesn’t touch serotonin. It works on dopamine and norepinephrine, which means it acts more like a mild stimulant than a sedating mood drug.

That single fact reshapes the entire conversation about who it’s for. If you imagine the SSRI patient as someone who walks in wound tight, ruminating, can’t sleep, jumpy, the Wellbutrin patient is the opposite. Flat. Slow. Can’t get out of bed. Lost the spark on whatever they used to enjoy. The classic low-energy, anhedonic depression. That patient on an SSRI often feels worse in the first month because you’ve taken someone who’s already running at 40 percent and slowed them down further. Wellbutrin pushes the opposite direction.

The chemical name is bupropion. It’s been on the market since the late eighties, came back from a brief withdrawal in the nineties after some seizure issues at the original dosing, and has been a workhorse ever since.

Who it’s actually right for

The textbook Wellbutrin candidate is someone with low-energy depression who also has one or more of these going on: they’re a smoker, they’re worried about sexual side effects, they don’t want to gain weight, or they’ve already tried an SSRI and felt either nothing or worse.

I had a guy come in last spring, mid-30s, software engineer, classic depression presentation. Sleeping eleven hours, dragging through his day, hadn’t gone to the gym in six months, gained twenty pounds, and to put a cherry on top, he’d quit smoking three months earlier and was white-knuckling it. His previous doctor had put him on Lexapro and he’d lasted about five weeks before quitting because he couldn’t get an erection and his weight was still climbing. He walked in pretty convinced antidepressants were a scam. We put him on Wellbutrin XL at 150 for two weeks, bumped to 300, and at the six-week follow-up he was back at the gym, hadn’t relapsed on cigarettes, and his wife was happy again. That’s about as clean a Wellbutrin story as you get in clinic. Most aren’t that tidy.

The sexual side effect piece is real and underdiscussed. SSRIs cause some degree of sexual dysfunction in something like 40 to 60 percent of patients, and most patients won’t bring it up unless you ask directly. Men under 50 in particular will quietly stop their medication rather than tell their psychiatrist their dick doesn’t work anymore. Wellbutrin doesn’t cause that, and it’s sometimes added to an SSRI specifically to rescue sexual function while keeping the SSRI’s serotonergic effect for mood or anxiety.

The weight thing matters too. SSRIs vary, but Paxil and Remeron in particular can put ten or fifteen pounds on someone in a year. Wellbutrin is weight neutral, sometimes mildly weight-losing in the first few months. For patients who already have a complicated relationship with their body, that distinction can be the difference between staying on the medication and quitting.

If your depression looks like sleeping all day and not caring about anything, you probably want activation. If it looks like crying at your desk and panicking about everything, you probably don’t.

Who it’s wrong for, and this list matters

Three groups should not be on Wellbutrin, and one group should be on it cautiously.

Anyone with a history of an eating disorder, particularly bulimia or anorexia, is a hard no. The seizure risk goes up substantially in low-BMI patients and in patients who are purging, because electrolyte derangement plus a seizure-threshold-lowering drug is a recipe for a very bad day. This shows up on the FDA black box. I follow it strictly. If a patient tells me about a college bulimia history from fifteen years ago, fully resolved, I’ll consider it carefully, but active or recent eating disorder is a line I don’t cross.

Anyone with a seizure disorder or a history of seizures, same answer. Wellbutrin lowers the seizure threshold more than most psychiatric meds. The risk at therapeutic doses on the XL formulation is small, somewhere around 0.1 percent, but it’s not zero, and there are other antidepressants that don’t have that issue.

Anyone with primary anxiety as the chief complaint. This is the one I see general practitioners get wrong the most. Someone walks into their PCP describing panic attacks and gets handed Wellbutrin because it was the newest thing or because the doctor was worried about SSRI weight gain. Two weeks later the patient is more anxious, more wired, sleeping worse, and convinced all psychiatric medication is poison. Wellbutrin is an activator. It will reliably make a primary anxiety presentation worse. If anxiety is part of the picture but depression is the driver, sometimes you can still use it, sometimes paired with a short-term benzodiazepine while it kicks in, but as a first-line for anxiety it’s the wrong tool.

The cautious group is anyone with a history of psychosis or mania. Dopaminergic drugs can destabilize bipolar patients into mania. Not impossible to use, but you’d better know what you’re doing and stay in close contact with the patient.

The smoking cessation angle

Same molecule, different brand name, different FDA indication. Zyban is bupropion at the same dose range used for depression, marketed for smoking cessation. It works. The mechanism isn’t fully understood, but it dampens the dopaminergic reward associated with nicotine and seems to reduce the withdrawal misery in the first few weeks.

What I tell patients who smoke and who are depressed is that we get to address two things with one prescription. If you’re going to be on an antidepressant anyway, and you’ve been thinking about quitting cigarettes, Wellbutrin makes the cigarette quit something like 30 to 40 percent more likely to stick at the one-year mark. Combine it with nicotine replacement and the numbers get better.

The other piece nobody mentions: a lot of depressed patients self-medicate with nicotine because it’s a mild dopamine and norepinephrine bump. Wellbutrin replaces some of that pharmacologically. Patients describe it as the first time in years they’ve gone a full day without thinking about a cigarette.

Dosing

150 to 300mg XL

Almost everyone starts at 150mg XL for two weeks, then goes to 300mg XL. The 450mg dose exists and gets used occasionally, but seizure risk climbs above 450. The IR and SR formulations still exist but XL is cleaner.

Timing

Mornings only

Activating, so taking it at night will wreck your sleep. Patients on Wellbutrin who report insomnia have almost always been told to take it after dinner. Move it to 7 AM and the insomnia usually resolves in a week.

Onset

Four to six weeks

Energy can lift in the first week or two, which is misleading. Real mood improvement still takes the usual four to six weeks. The first two weeks people sometimes feel jittery. That mostly settles.

Things people don’t get told

It can make you sweaty. Not subtle. Some patients drip through dress shirts for the first month and then it settles. Worth knowing before you take an important meeting in a gray shirt. It can also make you constipated and dry-mouthed. Both manageable. Both usually fade.

It is not a magic energy drug. I get patients who heard from a friend that Wellbutrin gave them their life back and they want to try it for fatigue or motivation, no actual depression. People sometimes conflate it with Adderall because they’ve heard the word stimulant attached to it. It’s a modest dopamine and norepinephrine reuptake inhibitor with mild activating properties, nothing close to a true stimulant. In a non-depressed person it’s mostly unremarkable.

It interacts with a real list of medications, especially other things that lower the seizure threshold. The Wellbutrin plus tramadol combination is one I always check for in patients coming over from another prescriber, because pain clinics and psychiatry don’t always talk to each other.

The biggest thing patients aren’t told: if Wellbutrin worked and you stop, the relapse profile is similar to other antidepressants. People stop because they feel great, assume they’re cured, and rediscover the depression three months later. The right reason to taper off is a stable patient, a stable life, and a real plan with your prescriber. Not a Tuesday in March when you ran out of refills.

For the right patient, Wellbutrin is one of the cleanest, most useful tools we have. For the wrong patient, it’s a fast way to make a bad situation worse. The art is mostly in figuring out which one is sitting across from you.